| Literature DB >> 32012927 |
Kamila Sofińska1, Natalia Wilkosz1, Marek Szymoński1, Ewelina Lipiec1.
Abstract
Every cell in a living organism is constantly exposed to physical and chemical factors which damage the molecular structure of proteins, class="Chemical">lipids, and nucleic acids. Cellular DNA lesions are the most dangerous because the genetic information, critical for the identity and function of each eukaryotic cell, is stored in the DNA. In this review, we describe class="Chemical">spect<class="Chemical">span class="Chemical">roscopic markers of DNA damage, which can be detected by infrared, Raman, surface-enhanced Raman, and tip-enhanced Raman spectroscopies, using data acquired from DNA solutions and mammalian cells. Various physical and chemical DNA damaging factors are taken into consideration, including ionizing and non-ionizing radiation, chemicals, and chemotherapeutic compounds. All major spectral markers of DNA damage are presented in several tables, to give the reader a possibility of fast identification of the spectral signature related to a particular type of DNA damage.Entities:
Keywords: DNA damage; DNA damage spectroscopic markers; DNA lesions; DSB; SSB; double strand breaks; single strand breaks
Mesh:
Substances:
Year: 2020 PMID: 32012927 PMCID: PMC7037412 DOI: 10.3390/molecules25030561
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Figure 1The scheme of exemplary DNA damaging factors, DNA lesion types (SSB—single strand breaks, DSB—double strand breaks), and possible repair mechanisms (BER—base excision repair, HR—homologous recombination, NHEJ—nonhomologous end-joining).
Figure 2Possible pathways of DSB formation upon C–O bond breakage in the DNA backbone.
The assignment of DNA damage marker bands.
| Damaging Factor | Spectral Change [cm−1] | Dynamics | Assignment | Ref. |
|---|---|---|---|---|
| Ionizing radiation | 2898–2891 |
| ν(C–H) deoxyribose and T | [ |
| 1671–1666 |
| ν(C=O), δ(NH2) dT, dG, dC, C/G/T, ν(C=C str), δs(NH2) | ||
| 1579–1576 |
| A/C/G/T rings | ||
| 1536–1531 |
| in–plane ring str. dC, T | ||
| 1491–1489 |
| ν(C=N) in imidiazole, dG, dA, | ||
| 1422–1418 |
| ν(C4–C5str) C A, T | ||
| 1339–1335 |
| dA, dG, A/G (ring mode) | ||
| 1245–1243 |
| νasym(O–P–O) | ||
| 1106–1100 |
| νsym(O–P–O) | ||
| 1016–1008 |
| ν(N–sugar) A | ||
| 690–670 |
| C2’–endo/anti, G ring breathing | ||
| 500–494 |
| C/T ring def. | ||
| Proton and γ radiation | 1715–1706 |
| ν(C6=O)-G | [ |
| 1702–1689 |
| ν(C6=O), δ(N1H2)-G | ||
| 1684–1683 |
| ν(C2=O)-C | ||
| 1670–1664 |
| ν(C4=O)-T | ||
| 1652–1645 |
| ν(C2=O)-T | ||
| 1612–1604 |
| ν(C5C6), δ(NH2)-A,G | ||
| 1545–1530 |
| ν(N3C4)-C | ||
| 1515–1508 |
| δ(N6H2) + ring-A | ||
| 1488–1482 |
| ring mode N7-G,A | ||
| 1464–1452 |
| δ(5′CH2)-dRib | ||
| 1427–1418 |
| δ(2′CH2)-dRib | ||
| 1374–1369 |
| ring mode δs(C5H3)-T,A,C | ||
| 1342–1327 |
| ν(C2N3)-A,G | ||
| 1306–1302 |
| ring mode-A,C | ||
| 1253–1244 |
| ring mode-C,T | ||
| 1100–1098 |
| νs(PO2−) | ||
| 1077 app | PO2−–strand breaks | |||
| 1062–1051 |
| ν(CO5′)-dRib | ||
| 1013–1003 |
| T,G,C,dRib | ||
| 985 app | ν(PO32−)-strand breaks | |||
| 970–960 |
| dRib | ||
| 948–941 |
| dRib | ||
| 935–927 |
| dRib | ||
| 918–914 |
| ν(CCO)-dRib | ||
| 890–882 |
| ν(CO)-dRib-P | ||
| 875 app | dRib-denaturation | |||
| 868–860 |
| ν(CO)-dRib-P | ||
| 836–825 |
| ν(O–P–O), B-type | ||
| 818–805 |
| ν(O–P–O), A-type | ||
| 784–781 |
| ring breathing-T,C | ||
| 755–746 |
| ring breathing-T | ||
| 730–727 |
| ring breathing-A | ||
| 683–669 |
| ring breathing-G | ||
| 626–612 |
| ring breathing-G,A,dRib | ||
| 599–592 |
| δ(CCO) + δ(CCC)-dRib; δ(C=O)-C, T | ||
| 572–563 |
| ring def.-C,T | ||
| 539–535 |
| ring def.-A | ||
| 500–497 |
| δ(PO2−); ring def. | ||
| 453–450 |
| ring def.-C | ||
| 424–416 |
| ring def.-T,C | ||
| 411–390 |
| δ(C=O)-T,G | ||
| 334–325 |
| ring def.-G,A,T | ||
| Bleomycin | 1456 |
| deoxyribose or guanine vibrations | [ |
| 1084 |
| ν(PO2) bk | ||
| 1044 |
| ν(PO43−) bk | ||
| 880 |
| C–C bk vibration | ||
| Ultraviolet C (UVC) | 1665–1657 |
| δs(NH2) | [ |
| 1571–1570 |
| in plane ring vibration A/G, δs(NH2) | ||
| 1482–1468 |
| ν(C=N) pyrimidine, C2H2 def. | ||
| 1418–1412 |
| ν(C6–N1) pyrimidine, ring | ||
| 1336–1332 |
| (C–N), ring | ||
| 1303–1293 |
| ring | ||
| 1240–1234 |
| νasym(O–P–O) | ||
| 1192–1183 |
| ν P–(OH) | ||
| 1089–1086 |
| νsym(O–P–O) | ||
| 1062–1060 |
| ν(N-sugar) A | ||
| 1020–1019 |
| ν(C8-N9, N9-H, C8-H) A | ||
| 982–963 |
| (CC, CO) T, ribose δr (NH2) T | ||
| 916–913 |
| δr (NH2) A/C/G, deoxyribose | ||
| 784–767 |
| T ring breathing | ||
| 680–630 |
| G ring breathing | ||
| Adriamycin/daunomycin | 1347–1338 |
| ring mode(G,A) | [ |
| 1149–1144 |
| deoxyribose-phosphate stretching | ||
| 1053–1044 |
| ν(C=O)/νsym PO2− | ||
| 962–951 |
| deoxyribose | ||
| 889–880 |
| deoxyribose/ν(O–P–O) | ||
| 808–800 |
| ν(O–P–O) vibration | ||
| 776–763 |
| ring breathing (C) | ||
| 701–692 |
| ring breathing(G) influence by C2′ endo sugar pucker | ||
| 675–673 |
| ring breathing(G) influence by C3′ endo sugar pucker | ||
| 636–633 |
| ring mode(T)/T breathing vibration | ||
| Platinum chemotherapeutic drugs | 1716–1711 |
| base pair carbonyl ν(C=O) | [ |
| 1238–1225 |
| νasym PO2− | ||
| 1088 |
| νsym PO2 | ||
| 1055 |
| ν(C–O) bk | ||
| 968–966 |
| ν(C–C) bk |
ν—stretching, νsym—symmetric stretching, νasym—asymmetric stretching, δ—bending, δs—scissoring (in plane bending), δr—rocking (out of plane bending), bk—backbone, def.—deformation, —decrease in intensity, —increase in intensity, —shift towards higher wavenumbers in relative to control, —shift towards lower wavenumbers in relative to control, app—band appearance relative to the control, A—adenine, C—cytosine, G—guanine, T—thymine.
Figure 3Surface-enhanced Raman spectroscopy (SERS) spectra of the HaCaT cell DNA exposed to H2O2/UV. Panels A–C indicate regions of interest with characteristic SERS bands of DNA. From top to bottom: SERS spectra collected after 0, 5, 10, 15, and 20 min of exposure to reactive oxygen species (ROS); adapted with permission from [86].
The assignment of bands in the SERS spectra of DNA treated with various damaging factors.
| Damaging Factor | Spectral Change | Dynamics | Assignments | Ref. |
|---|---|---|---|---|
| H2O2/UV | 1502 |
| G, A (oxidation of guanosine by ROS) | [ |
| 1438 |
| (C5′–H2) def. T | [ | |
| 1387 |
| A, T, and G ring vibrations | [ | |
| 1334 |
| A ring vibration | ||
| 1179 |
| unpaired T | [ | |
| 1159 |
| A ring vibration | [ | |
| 1085–1075 |
| νsym(PO2−), bk | [ | |
| 800 | νsym(O–P–O) | |||
| 740 spl. to 715 and 738 | A, T ring breathing | [ | ||
| 660–640 |
| G ring breathing (vibration sensitive to orientation relative to the ribose ring) | [ | |
| ROS inducted during PDT | 1445–1430 |
| ribose; breakage of DNA backbone structure | [ |
| 1337 |
| A, cleavage of the double chain | ||
| 1214–1208 |
| A, cleavage of the double chain | ||
| 1092 |
| νsym(O–P–O); damage of DNA double-helix structure | ||
| UV–A | 1660 | ν(C=O), δs(NH2) | [ | |
| 1585 | ν(C=C, N–C) | |||
| 1480, 1510 | ν(N–C) | |||
| 1378 | δ(C–H), ν(C–N–C) | |||
| 1270 | ν(N–C) | |||
| 1056, 1098 | νsym(PO2−) | |||
| 904 | ν(C–C) | |||
| 802–843 | νsym(O–P–O), δ(N–H, C–H) | |||
| 674–703 | G ring breathing, δ(C–C, N–C) | |||
| UV-C | 1684 dis. | ν(C=O), δ(NH2) of T/G/C, base stacking vibration | [ | |
| 1667–1660 |
| δs(NH2) | [ | |
| 1581–1573 |
| in plane ring vibration A/G, δs(NH2) | [ | |
| 1519–1507 |
| ring | [ | |
| 1484–1478 |
| ν(C=N) pyrimidine, (C2H2) def. | [ | |
| 1440 app. | δr(CH2) | [ | ||
| 1402–1400 |
| ν(C6–N1) pyrimidine, ring | [ | |
| 1370 app. | δs(CH2, CH3) | [ | ||
| 1324–1313 |
| (C–N), ring | [ | |
| 1324–1311 |
| ring | [ | |
| 1254–1245 |
| νasym(O–P–O) | [ | |
| 1202–1198 |
| ν P–(OH) | [ | |
| 1128–1090 |
| νsym(O–P–O) | [ | |
| 1070–1068 |
| ν(N–sugar) A | [ | |
| 1030 dis. | ν(C8–N9, N9–H, C8–H) A | [ | ||
| 930 app. | δr(NH2) A/C/G, deoxyribose | [ | ||
| 880 app. | deoxyribose ring | [ | ||
| 850–841 |
| deoxyribose ring | [ | |
| 786–780 |
| T ring breathing | [ | |
| 658–648 |
| G ring breathing | [ | |
| X-ray | 1577–1563 | A, G ring vibration | [ | |
| 1509–1503 | A | |||
| 1420–1414 | A, G | |||
| 1336–1333 |
| A, G ring vibration | ||
| 1176–1162 | T, C, G, | |||
| 1134–1119 | ν(C–N) | |||
| 1095–1086 | νsym(O–P–O) | |||
| 893–884 | phosphodiester bk, deoxyribose | |||
| 792–783 |
| unpaired T, C, νsym(O–P–O), bk | ||
| 769–767 | C, T ring breathing | |||
| 736–730 | A ring breathing | |||
| 686–683 | G ring breathing | [ | ||
| Doxorubicin | 1642 |
| ν(C=O), hydrogen-bonding to the C=O | [ |
| 1591 app. | complex formation | |||
| 1586–1571 |
| A; doxorubicin interaction with the N7 position of A, which is accessible for doxorubicin in the DNA structure | ||
| 1467 | G, (C8H-N9C8 and C8N7) | |||
| 1372–1312 |
| T, def. of the hydrogen bond between the NH2 group of A and the C40 group of T, δ(ring C20/15 and C16–OH) | ||
| 1318 |
| A; doxorubicin interaction with the N7 position of A | ||
| 1273 app. | _ν(C–O) of ring A of doxorubicin | |||
| 1246, 1214 |
| δs(C–O, C–O–H, C–H) intercalation of rings B and C of doxorubicin within the double helix. | ||
| 1123 | ν(C–N) | |||
| Cisplatin | 1726 |
| ν(C=O) G | [ |
| 1665 |
| ν(C=O), (N–H) def. of T/G/C | ||
| 1588 |
| G vibration | ||
| 1485 |
| cisplatin (electrophilic agent) binding to the N7 atom of G | [ | |
| 1333 |
| G vibration | [ | |
| 541 app. | Pt-NH3 stretching of cisplatin ligands | [ |
ν—stretching, νsym—symmetric stretching, νasym—asymmetric stretching, δ—bending, δs—scissoring (in plane bending), δr—rocking (out of plane bending), bk—backbone, def.—deformation, decrease in intensity, increase in intensity, shift towards higher wavenumbers relative to control, shift towards lower wavenumbers relative to control, dis.—band disappearance relative to the control, app.—band appearance relative to the control, spl.—splitting of SERS bands, A—adenine, C—cytosine, G—guanine, T—thymine.
Figure 4The SERS spectra of mitochondria isolated from MCF-7 cells following photodynamic therapy (PDT) treatment for 0, 1, 3, and 5 min; λex = 632.8 nm, t = 10 s and accumulation = 2 times, adapted with permission from [95].
The assignment of bands in TERS spectra of DNA following UV–C exposure [15].
| Damaging Factor | Spectral Change [cm−1] | Dynamics | Assignments | Ref. |
|---|---|---|---|---|
| UV-C | 1702 dis. | ν(C=O), δ(NH2) of | [ | |
| 1653–1651 |
| δs(NH2) | [ | |
| 1578–1571 |
| in plane ring vibration A/G, δs(NH2) | [ | |
| 1515–1512 |
| Ring | [ | |
| 1483–1472 |
| ν(C=N) pyrimidine, (C2H2) def. | [ | |
| 1440 app. | δr (CH2) | [ | ||
| 1406–1403 |
| ν(C6–N1) pyrimidine, ring | [ | |
| (1365–1350) app. | δs(CH2, CH3) | [ | ||
| 1328–1317 |
| (C–N), ring | [ | |
| 1296−(1313–1296) | ring | [ | ||
| 1237–1234 |
| νasym(O–P–O) | [ | |
| 1190 app. | ν P–(OH) | [ | ||
| 1160 app. | δ(P–O–H) | [ | ||
| 1115 | νsym (P–O–C), νsym (O–P–O) | [ | ||
| 1085–1079 |
| νsym(O–P–O) | [ | |
| 1067–1061 |
| ν(N–sugar) A | [ | |
| 1034 app. | ν(C8–N9, N9–H, C8–H) A | [ | ||
| 980 app. | ν(CC, CO) T, ribose; δr(NH2) T | [ | ||
| 930 app. | δr(NH2) A/C/G, deoxyribose | [ | ||
| 870 app. | deoxyribose ring | [ | ||
| 830 app. | deoxyribose ring | [ | ||
| 655 app. | G ring breathing | [ |
ν—stretching, νsym—symmetric stretching, νasym—asymmetric stretching, δ—bending, δs—scissoring (in plane bending), δr—rocking (out of plane bending), bk—backbone, def.—deformation, decrease in intensity, increase in intensity, shift towards higher wavenumbers relative to control, shift towards lower wavenumbers relative to control, dis.—band disappearance relative to the control, app.—band appearance relative to the control, A—adenine, C—cytosine, G—guanine, T—thymine.
Influence of chemical and physical damaging factors on Raman and IR spectral markers in cells.
| Damaging Factor | Type of Damage | Spectral Change | Dynamics | Assignment | Ref. |
|---|---|---|---|---|---|
| UV-A + UV-B | base-pair damage such as purine and pyrimidine dimer formation along with 6–4 lesions | 1714 |
| base stacking mode | [ |
| DNA conformation change | 1245–1230 |
| νasym(O–P–O) | ||
| DNA fragmentation, apoptosis | 1080 |
| νsym(O–P–O) | [ | |
| Protons | local rupture of base-paired structures | 1714 |
| Base stacking mode | [ |
| hydrogen bonding structure in DNA typical for apoptotic cells, changes in the deoxyribose/ribose structure | 1242 |
| νasym(O–P–O) | [ | |
| 1157 |
| –C–OH | |||
| DNA fragmentation, apoptosis | 1080 |
| νsym (O–P–O) | ||
| DNA fragmentation, apoptosis | 970–963 |
| ν(C–C), ν(C–O) | [ | |
| SSB, DSB, crosslinks, and deoxyribose damage | 970 |
| ribose-phosphate skeletal motions | [ | |
| γ and X rays | base–pair damage including purine, pyrimidine dimer formation and 6–4 lesions | 1713 |
| Base stacking mode | [ |
| partial structural transition from B-DNA and A-DNA | 1240–1220 |
| νasym(O–P–O) | ||
| 1080 |
| νasym(O–P–O) | |||
| DNA fragmentation | 1036, 1020 | ||||
| DNA damage, fragmentation | 791 |
| νsym(O–P–O) | ||
| 784 |
| ring breathing vibrations of DNA base pairs | |||
| Doxorubicin | DNA phosphates backbone changes because of the DNA disintegrating effect of doxorubicin | 1085 |
| νsym(O–P–O) | [ |
| 1050 |
| ν(C–O) | |||
| Platinum chemotherapeutic compounds:cisplatin, carboplatin | phosphodiester bonds breakage and DNA bases | 1576 |
| A, G | [ |
| phosphodiester bonds breakage and DNA bases | 1523 |
| C | ||
| the change of the DNA content (not change of the double helix structure) | 1338 | the polynucleotide chain (DNA–purine bases) | |||
| nonhydrogen-bonded phosphodiester groups of nucleic acids are bonded to a heavy group in cisplatin | (1223–1221) |
| hydrogen-bonded phosphodiester groups | [ | |
| modification of the interchain packing of the DNA | 1087 |
| νsym(O–P–O) | ||
| breakdown of phosphodiester bonds and DNA bases | 783 |
| ν(O–P–O) | ||
| Paclitaxel | DNA condensation, apoptosis | 1036, 1020 |
| C–O stretch of carbohydrates convoluted with skeletal trans conformation (C–C) | [ |
ν—stretching, νsym—symmetric stretching, νasym—asymmetric stretching, δ—bending, δs—scissoring (in plane bending), δr—rocking (out of plane bending), δw—wagging, δt—twisting, bk—backbone, def.—deformation, —decrease in intensity, —increase in intensity, —shift to higher wavenumbers, —shift to lower wavenumbers, A—adenine, G—guanine, C—cytosine.
Figure 5The average spectra collected from isolated COLO-679 cellular nuclei and (a) living COLO-679 cells (b) control and irradiated cells with exposure to 3 different UV doses, followed by incubation for 48 h; adapted with permission from [112].